Crsp stock forecast 2025.

Sep 19, 2023 · 32.69%. Dividend Yield. N/A. More importantly, CRISPR Therapeutics' financial results should improve in the next five years. The company is on the verge of receiving approval for exa-cel, a gene ...

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.Editas Medicine (EDIT) stock price prediction is 21.770642845038 USD. The Editas Medicine stock forecast is 21.770642845038 USD for 2024 November 30, Saturday; and 92.327 USD for 2028 November 30, Thursday with technical analysis.According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of 1.79%. The lowest target is $42 and the highest is $110. On average, analysts rate CRSP stock stock as a buy. Analyst Consensus: Buy Analyst Ratings1.76%. $20.2M. Plandai Biotechnology Inc. -20.00%. $1.94M. CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions.

CRT stock forecast for 2023 – 2027. Last updated: November 23, 2023. Cross Timbers Royalty Trust. 20.01 D 0.15% (0.03) Are you interested in Cross Timbers Royalty Trust stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CRT stock price in 2022-2027. Is CRT a good long term stock?Stock forecasts » CRSP » 2025. CRISPR Therapeutics (CRSP) stock consensus forecasts for 2025. Last update: 06/17/2023, 02:26 AM. Brief information about CRISPR …CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew …

The average Editas Medicine stock forecast 2024 represents a 3.79% increase from the last price of $10.5299997329712. For Editas Medicine stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Editas Medicine stock forecast of $10.98, a high forecast of $12.02, and a low forecast of $10.15.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below. According to present data Editas Medicine's EDIT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

Price target in 14 days: 89.877 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Teladoc Health share forecasts, stock quote and buy / sell signals below. According to present data Teladoc Health's TDOC shares and potentially its market environment have been in bearish cycle last 12 months (if exists).SGMO Stock 12 Months Forecast. $3.09. (599.73% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $3.09 with a high forecast of $7.00 and a low forecast of $1.00. The average price target represents a 599.73% change from the last price of $0.44.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rambus share forecasts, stock quote and buy / sell signals below. According to present data Rambus's RMBS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

CRISPR Therapeutics AG research and ratings by Barron's. View CRSP revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

The average Romeo Power stock forecast 2025 represents a 26.03% increase from the last price of $0.740000009536743. For Romeo Power stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Romeo Power stock forecast of $0.94, a high forecast of $0.94, and a low forecast of $0.94. ...

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...CRISPR Therapeutics stock prediction for June 2025. In the beginning at 81.08. Maximum 90.30, minimum 76.92. The averaged price 82.98. At the end of the month 83.61 dollars, change for June 3.1%. CRISPR Therapeutics stock price forecast for July 2025. In the beginning at 83.61. Maximum 92.20, minimum 78.54. The averaged price 84.93.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...Jun 21, 2023 · CRISPR stock has climbed more than 40% so far this year. An important moment may be only a few months away for CRISPR Therapeutics ( CRSP -2.22%). I'm talking about the potential approval of its ... Butterfly Network Inc - Class A Stock Forecast, BFLY stock price prediction. Price target in 14 days: 1.290 USD. ... Class A Stock Price Forecast for 2025: January ...Find real-time ABNB - Airbnb Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time NCLH - Norwegian Cruise Line Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.

The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...Mar 9, 2021 · CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price. Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.Competitors. The 26 analysts offering 12-month price forecasts for Halliburton Co have a median target of 49.50, with a high estimate of 56.00 and a low estimate of 44.00. The median estimate ...Oct 10, 2023 · CRISPR Therapeutics Stock Forecast 2023. In the last five quarters, CRISPR Therapeutics’s Price Target has risen from $0.00 to $40.65 - a 100% increase. One analysts predict that CRISPR Therapeutics’s share price will increase in the coming year, reaching $150.00. This would represent an increase of 269%. Jan 13 Show all updates Earnings and Revenue Growth Forecasts Show more Analyst Future Growth Forecasts Earnings vs Savings Rate: CRSP is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CRSP is forecast to remain unprofitable over the next 3 years.

General Motors Company () Stock Market info Recommendations: Buy or sell General Motors stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the General Motors share forecasts, stock quote and buy / sell signals below.According to present data General Motors's GM shares and potentially its market …

The Butterfly Network, Inc. stock price gained 5.01% on the last trading day (Friday, 1st Dec 2023), rising from $0.95 to $1.00. During the last trading day the stock fluctuated 7.45% from a day low at $0.94 to a day high of $1.01. The price has fallen in 6 of the last 10 days and is down by -9.91% for this period.Forecast . Price target. 89.68 0.00 0.00%. The 22 analysts offering 1 year price forecasts for CRSP have a max estimate of — and a min estimate of —. Analyst rating. Based on 28 analysts giving stock ratings to CRSP in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreFind real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...CRISPR Therapeutics AG (CRSP) stock price prediction is 130.64207402132 USD. The CRISPR Therapeutics AG stock forecast is 130.64207402132 USD for 2024 November 24, Sunday; and 586.145 USD for 2028 November 24, Friday with technical analysis.Unraveling CRISPR Therapeutics (CRSP) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing CRISPR Therapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Stock forecasts » CRSP » 2025. CRISPR Therapeutics (CRSP) stock consensus forecasts for 2025. Last update: 06/17/2023, 02:26 AM. Brief information about CRISPR …The Veracyte stock forecast is 49.167390804547 USD for 2024 November 20, Wednesday; and 222.634 USD for 2028 November 20, Monday with technical analysis. Veracyte (VCYT) stock price prediction is 49.167390804547 USD.

Forecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...

Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...

Find real-time NOK - Nokia Oyj stock quotes, company profile, news and forecasts from CNN Business.Competitors. The 26 analysts offering 12-month price forecasts for Halliburton Co have a median target of 49.50, with a high estimate of 56.00 and a low estimate of 44.00. The median estimate ...3 equities research analysts have issued 12 month price objectives for Cameco's shares. Their CCJ share price targets range from $25.00 to $56.00. On average, they expect the company's share price to reach $35.33 in the next twelve months. This suggests that the stock has a possible downside of 22.2%.The CRISPR Therapeutics stock price gained 2.88% on the last trading day (Friday, 1st Dec 2023), rising from $66.73 to $68.65. During the last trading day the stock fluctuated 8.38% from a day low at $63.39 to a day high of $68.70. The price has been going up and down for this period, and there has been a 15.92% gain for the last 2 weeks.The Trimble stock forecast is 92.58442711926 USD for 2024 November 09, Saturday; and 383.563 USD for 2028 November 09, Thursday with technical analysis. Trimble (TRMB) stock price prediction is 92.58442711926 USD.Target values for the price of one CRISPR Therapeutics share for Feb 2024. The weighted average target price per CRISPR Therapeutics share in Feb 2024 is: 73.57. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 7.132% volatility is expected. Pessimistic target level: 70.51.Nov 10, 2023 · CRISPR Therapeutics Stock Forecast 30 Nov. Presumably, on 11/30/2023, the price of shares will be in the range of $51.94 - $53.92. A $1.98 range width can provide 3.81% volatility. The weighted average price of this range is at $53.49, which is $0.93 higher than the previous day's weighted average price. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Salesforce share forecasts, stock quote and buy / sell signals below. According to present data Salesforce's CRM shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).CRSP - CRISPR Therapeutics AG Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)The CRISPR Therapeutics stock price gained 2.88% on the last trading day (Friday, 1st Dec 2023), rising from $66.73 to $68.65. During the last trading day the stock fluctuated 8.38% from a day low at $63.39 to a day high of $68.70. The price has been going up and down for this period, and there has been a 15.92% gain for the last 2 weeks.Sep 5, 2023 · And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ... CPRX Stock 12 Months Forecast. $23.30. (81.32% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $23.30 with a high forecast of $27.00 and a low forecast of $15.50. The average price target represents a 81.32% change from the last price of $12.85.

Nokia will start 2030 at $6.41, then soar to $6.54 within the first half of the year, and finish 2030 at $6.68. It is about +88% from today. Nokia Stock Price Forecast 2023-2024. Nokia price started in 2023 at $4.64. Today, Nokia traded at $3.49, so the price decreased by -25% from the beginning of the year.About the Roku, Inc. stock forecast. As of 2023 November 30, Thursday current price of ROKU stock is 106.720$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Roku Inc - Class A stock price as been showing a rising tendency so we believe that similar market segments …The average Romeo Power stock forecast 2025 represents a 26.03% increase from the last price of $0.740000009536743. For Romeo Power stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Romeo Power stock forecast of $0.94, a high forecast of $0.94, and a low forecast of $0.94. ...Wall Street is still looking for Teladoc Health's stock to double to $180 per share in the next year, and revenue is expected to jump from $1.1 billion in 2020 to $5 billion for a 35% CAGR. So an ...Instagram:https://instagram. where to buy futures contractswho own modelofarmland stocksbest entry and exit indicators Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. psikolog onlinecharles schwab best index funds Stock Price Forecast According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of … books for value investing About the The Walt Disney Co. stock forecast. As of 2023 December 01, Friday current price of DIS stock is 92.210$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Walt Disney Co (The) stock price has been showing a declining tendency so we believe that similar market segments …CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 21, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics AG (CRSP) now CRISPR Therapeutics AG 69.97 D 0.74% (0.52) What analysts predict: $87.78 52-week High/Low: $76.19 / $37.55 50/200 Day Moving Average: $46.64 / $51.55Financial traders can chatter all they want about Apple's earnings miss, but there's data indicating strong upside potential for AAPL stock. A rare earnings miss for Apple doesn't mean you should dump AAPL stock Source: Vytautas Kielaitis /...